Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06576180 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma

Name: Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma — clinical trial record (NCT06576180)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusUnknown

PhaseNot specified

SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Started2024-08-23

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 28, 2024 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06

Trial status changed: Recruiting → Unknown

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

247 trials monitored

See 2 trials at risk

Head & Neck Cancer

2,051 trials monitored

See 116 trials at risk

The goal of this observational study is to learn about the Effects of neoadjuvant therapy with carboplatin, paclitaxel combined with anti-PD-1 drugs on cognitive function in patients with resectable head and neck squamous cell carcinoma: a prospective cohort study

Trial Details

NCT Number	NCT06576180
Lead Sponsor	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions	Head and Neck Squamous Cell Carcinoma
Enrollment	306 participants
Start Date	2024-08-23
Primary Completion	2024-09-01 (estimated)
Study Completion	2026-09-01 (estimated)
Updated on ClinicalTrials.gov	2024-08-28